Showing results (91-100 of 115) with videos related to
Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replicationD L Romero, M Busso, C K Tan, et al.American Journal of Clinical Oncology|February 1, 2011
Results of the 2005 to 2008 Association of Residents in Radiation Oncology surveys of chief residents in the United States: didactics and research experienceVinai Gondi, Johnny Ray Bernard, Siavash Jabbari, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2017
Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II TrialAtif J Khan, Matthew M Poppe, Sharad Goyal, et al.International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Results of the 2005-2008 Association of Residents in Radiation Oncology survey of chief residents in the United States: clinical training and resident working conditionsVinai Gondi, Johnny Ray Bernard, Siavash Jabbari, et al.The Journal of Biological Chemistry|June 2, 1995
The differential processing of homodimers of reverse transcriptases from human immunodeficiency viruses type 1 and 2 is a consequence of the distinct specificities of the viral proteasesN Fan, K B Rank, J W Leone, et al.Biochemistry|July 30, 1996
A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradationN Fan, K B Rank, D E Slade, et al.Cancer Medicine|September 15, 2020
Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry studyPeter G Hendrickson, Yukun Luo, Wendy Kohlmann, et al.International Journal of Radiation Oncology, Biology, Physics|January 7, 2019
Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Brachytherapy Applicators Is Feasible and Safe: First Results From the TRIUMPH-T TrialAtif J Khan, Peter Y Chen, Catheryn Yashar, et al.Antimicrobial Agents and Chemotherapy|May 1, 1997
Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitorS M Poppe, D E Slade, K T Chong, et al.Pediatric Dermatology|September 18, 2023
Safety and efficacy of topical nitric oxide-releasing berdazimer gel for molluscum contagiosum clearance: A systematic review and meta-analysis of randomized controlled trialsIzabela Pera Calvi, Isabela R Marques, Sara A Cruz, et al.Pageof 12